Compare CMPX & SHEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CMPX | SHEN |
|---|---|---|
| Founded | 2014 | 1902 |
| Country | United States | United States |
| Employees | N/A | 1041 |
| Industry | Biotechnology: Pharmaceutical Preparations | Telecommunications Equipment |
| Sector | Health Care | Telecommunications |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 927.5M | 878.5M |
| IPO Year | 2020 | 1994 |
| Metric | CMPX | SHEN |
|---|---|---|
| Price | $2.06 | $15.82 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 9 | 1 |
| Target Price | $14.57 | ★ $26.00 |
| AVG Volume (30 Days) | ★ 12.1M | 340.5K |
| Earning Date | 05-06-2026 | 05-01-2026 |
| Dividend Yield | N/A | ★ 0.73% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $357,854,000.00 |
| Revenue This Year | N/A | $7.12 |
| Revenue Next Year | $934.41 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 9.08 |
| 52 Week Low | $1.61 | $9.67 |
| 52 Week High | $6.88 | $17.35 |
| Indicator | CMPX | SHEN |
|---|---|---|
| Relative Strength Index (RSI) | 34.36 | 48.79 |
| Support Level | $1.61 | $14.10 |
| Resistance Level | $3.54 | $17.13 |
| Average True Range (ATR) | 0.14 | 0.62 |
| MACD | 0.13 | -0.05 |
| Stochastic Oscillator | 78.75 | 30.15 |
Compass Therapeutics Inc is a clinical-stage oncology-focused biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to target the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-A, Bispecific, and CTX-8371.
Shenandoah Telecommunications Co with its subsidiaries, provides various broadband communication products and services via its wireless, cable, fiber optic, and fixed wireless networks to customers in the Mid-Atlantic United States. The company operates through one business unit: Broadband. The broadband segment provides broadband Internet, video, and voice services to residential and commercial customers. The broadband segment generates the vast majority of the company's revenue, with the bulk of sales flowing from residential and small, and medium businesses within the broadband unit.